Our Team
Doron Therapeutics will operate a largely outsourced model, with a small group of highly experienced individuals coordinating CROs, CMOs, consultants, and advisors.
Doron Founders
Alessandra Pavesio
CEO
Executive sponsor of the program at Bioventus. Over 30 years of leadership experience in development of joint preservation technologies (Fidia, Anika, Bioventus). Previously led 6 programs in OA/cartilage preservation-all of which have become FDA/CE approved commercial products.
Sarah Caley
Head of Business Development and Strategy
20+ years in Business Development and Corporate Strategy. Led and completed over 25 successful transactions across multiple verticals for public and private companies.
Contact Us
Our team can help to answer any of your questions.
Get in touch to learn more about Doron Therapeutics.